Ching‐Hsuan Liu

3.3k citations
33 papers · 597 indexed · h-index 16
Topics
Virus-based gene therapy research (5 papers)Herpesvirus Infections and Treatments (5 papers)Hepatitis C virus research (5 papers)

In The Last Decade

Ching‐Hsuan Liu

30 papers receiving 578 citations

Peers

Ching‐Hsuan Liu
Comparison fields: 5 of 89
  • Molecular Biology 202
  • Epidemiology 122
  • Pharmacology 97
  • Infectious Diseases 95
  • Immunology 88
Replace Alagie Jassey with:
Alagie Jassey Taiwan
Jung Sun Min South Korea
Fahad Said Khan Pakistan
Aqel Albutti Saudi Arabia
Chin-Kai Tseng Taiwan
Ben-Dong Fu China
Entao Li China
Jianping Dai China
Qingjiao Liao China
Syed Muhammad Ali Shah Pakistan
Ching‐Hsuan Liu relative to Alagie Jassey Taiwan Alagie Jassey's profile →
Citations per field
00.5×1.5×
Alagie Jassey · 1×
Citations per year

Countries citing papers authored by Ching‐Hsuan Liu

Since Specialization
Citations

This map shows the geographic impact of Ching‐Hsuan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching‐Hsuan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching‐Hsuan Liu more than expected).

Fields of papers citing papers by Ching‐Hsuan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching‐Hsuan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching‐Hsuan Liu. The network helps show where Ching‐Hsuan Liu may publish in the future.

Co-authorship network of co-authors of Ching‐Hsuan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Ching‐Hsuan Liu. A scholar is included among the top collaborators of Ching‐Hsuan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching‐Hsuan Liu. Ching‐Hsuan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 2
5 0
6 5
7 45
8 2
9 16
10 20
11 7
12 13
13 13
14 1
15 25
16 15
17 49
18 13
19
A step-wise diagnosis of fragile X syndrome in Taiwan.
5
20 19

About Ching‐Hsuan Liu

Ching‐Hsuan Liu is a scholar working on Hepatology, Pharmacology and Infectious Diseases, having authored 33 papers that have together received 597 indexed citations. Recurring topics across this work include Virus-based gene therapy research (5 papers), Herpesvirus Infections and Treatments (5 papers) and Hepatitis C virus research (5 papers). The work is most often cited by research in Pharmacology (97 citations), Drug Discovery (1 citation) and Infectious Diseases (95 citations). Ching‐Hsuan Liu has collaborated with scholars based in Taiwan, Canada and United States. Frequent co-authors include Liang Lin, Alagie Jassey, Christopher D. Richardson, Ming-Hong Yen, Chen‐Jei Tai, Cheng-Jeng Tai, Chun-Ching Lin, C. Richardson, Chien‐Ju Lin and Chun A. Changou. Their work appears in journals such as Gut, Scientific Reports and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026